On Nov 09, major Wall Street analysts update their ratings for $Dentsply Sirona (XRAY.US)$, with price targets ranging from $20 to $30.
Morgan Stanley analyst Erin Wright maintains with a buy rating, and maintains the target price at $30.
J.P. Morgan analyst Rachel Vatnsdal maintains with a hold rating, and adjusts the target price from $27 to $24.
BofA Securities analyst Allen Lutz maintains with a hold rating.
Evercore analyst Elizabeth Anderson CFA maintains with a buy rating, and adjusts the target price from $27 to $20.
Baird analyst Jeff Johnson maintains with a hold rating, and adjusts the target price from $31 to $24.
Furthermore, according to the comprehensive report, the opinions of $Dentsply Sirona (XRAY.US)$'s main analysts recently are as follows:
With ongoing pressures in implants and equipment sectors, it is anticipated that shares might experience a decline. Despite the shares reaching historically low valuations, there are numerous challenges unique to the company, apart from macroeconomic factors, that suggest caution before engaging at the present valuations.
Here are the latest investment ratings and price targets for $Dentsply Sirona (XRAY.US)$ from 6 analysts:
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
